Acquiring Company
Little Green Pharma Ltd
Acquired Company
Unnamed Domestic Peer
West Perth
AustraliaBiotechnologyHealth CareMedicalNon ProfitCannabisBiotechnologyCannabisDescription
Little Green Pharma Ltd has agreed to a merger structured as a reverse takeover with a privately owned domestic peer. This merger aims to build a vertically integrated supplier for the European medicinal cannabis market. The strategic rationale is to leverage European demand, enhancing the operational footprint of both companies. This move comes after a challenging trading year for Little Green Pharma, marked by revenue declines.
Don't miss Little Green Pharma Ltd's next move
Get an email the moment Little Green Pharma Ltd makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Unnamed Domestic Peer?
Unnamed Domestic Peer was acquired by Little Green Pharma Ltd, based in West Perth. The deal was reported on August 25, 2026. Little Green Pharma Ltd is an Australian company focused on the cultivation and distribution of medicinal cannabis products. It aims to deliver effective and affordable treatments for various medical conditions. Little Green Pharma Ltd is privately held and operates in Biotechnology.
When did Little Green Pharma Ltd acquire Unnamed Domestic Peer?
Little Green Pharma Ltd's acquisition of Unnamed Domestic Peer was reported on August 25, 2026. Little Green Pharma Ltd has agreed to a merger structured as a reverse takeover with a privately owned domestic peer. This merger aims to build a vertically integrated supplier for the European medicinal cannabis market. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Unnamed Domestic Peer do?
The acquiree is a domestically owned peer of Little Green Pharma involved in the cultivation of cannabis. This company operates in the competitive Australian medicinal cannabis market. Details about this specific entity are not publicly outlined. It is privately held, operating in Biotechnology, and is based in Australia.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.